Stockscreener 앱 받기
0.22
13.39%
-0.034
Processa Pharmaceuticals Inc 주식(PCSA)의 최신 뉴스
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewswire
FDA Project Optimus: Processa Unveils New Approach for Rare Disease Treatment Success - Stock Titan
Data-Based Insights About Processa Pharmaceuticals Inc (PCSA) - stocksregister.com
Processa Pharmaceuticals stock hits 52-week low at $0.22 - Investing.com
Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN
Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com
Processa Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com UK
Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World
Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com South Africa
Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com
Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times
Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan
Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia
Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India
Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart
Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com
Processa Pharma Stock Price, Quotes and Forecasts - Benzinga
The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl
Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions
Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria
Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World
Processa Pharmaceuticals faces Nasdaq delisting risk over share price - Investing.com
Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com
Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater
Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire
Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan
Gastroparesis Market Expected to rise, 2034 | Vanda - openPR
Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 - MSN
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
Processa Pharmaceuticals Raises $5M in Public Offering - TipRanks
Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise - StockTitan
Processa Pharmaceuticals director David Young buys $99,288 in stock - Investing.com India
Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Processa Pharmaceuticals' chief business officer buys $34,691 in stock By Investing.com - Investing.com South Africa
Processa Pharmaceuticals director David Young buys $99,288 in stock By Investing.com - Investing.com South Africa
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 By Investing.com - Investing.com UK
2.51%
자본화:
|
볼륨(24시간):